The present invention relates to a compound inhibiting the expression and/or the activity of maternally expressed 3 (Meg3) for use in treating or preventing cardiac remodelling.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11186838 LNCRNA MEG3 for therapy and diagnosis of cardiac remodelling

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API

US Patent 11186838 LNCRNA MEG3 for therapy and diagnosis of cardiac remodelling

Contents

Patent attributes

Timeline

Further Resources

References

Find more entities like US Patent 11186838 LNCRNA MEG3 for therapy and diagnosis of cardiac remodelling